Germany has also backtracked on their initial ruling on AstraZeneca, now approving the vaccine for over-65s. Chancellor Angela Merkel had called on the country’s independent vaccine committee to change course due to new data from a Scottish government study, which showed AstraZeneca’s
The Chancellor is said to be considering a number of tax hikes and reforms in order to recoup funds, and will outline his policy changes in his Budget on March 3. Julia Rosenbloom, a partner and Smith and Williamson and tax adviser,
